Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrdad Rakaee

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Plos One|November 16, 2017
Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohortElin Richardsen, Sigve Andersen, Samer Al-Saad, et al.
Oncotarget|May 3, 2017
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohortNora Ness, Sigve Andersen, Mehrdad Rakaee Khanehkenari, et al.
Neoplasia (New York, N.Y.)|February 12, 2019
Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex ImmunohistochemistryMehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, et al.
Scientific Reports|July 29, 2018
Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progressionThea Grindstad, Elin Richardsen, Sigve Andersen, et al.
Cancers|August 27, 2021
Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer-A Multi-Institutional StudyMaria J Stoen, Sigve Andersen, Mehrdad Rakaee, et al.
Human Pathology|June 10, 2018
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancerMehrdad Rakaee, Thomas K Kilvaer, Stig Manfred Dalen, et al.
Clinical Lung Cancer|November 7, 2016
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore ApproachErna-Elise Paulsen, Thomas K Kilvaer, Mehrdad Rakaee Khanehkenari, et al.
Scientific Reports|September 10, 2016
Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcomeThea Grindstad, Kaja Skjefstad, Sigve Andersen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung CancerRoy M Bremnes, Lill-Tove Busund, Thomas L Kilvær, et al.
Clinical Lung Cancer|February 4, 2018
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved SurvivalSigurd M Hald, Mehrdad Rakaee, Inigo Martinez, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Plos One|November 16, 2017
Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohortElin Richardsen, Sigve Andersen, Samer Al-Saad, et al.
Oncotarget|May 3, 2017
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohortNora Ness, Sigve Andersen, Mehrdad Rakaee Khanehkenari, et al.
Neoplasia (New York, N.Y.)|February 12, 2019
Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex ImmunohistochemistryMehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, et al.
Scientific Reports|July 29, 2018
Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progressionThea Grindstad, Elin Richardsen, Sigve Andersen, et al.
Cancers|August 27, 2021
Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer-A Multi-Institutional StudyMaria J Stoen, Sigve Andersen, Mehrdad Rakaee, et al.
Human Pathology|June 10, 2018
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancerMehrdad Rakaee, Thomas K Kilvaer, Stig Manfred Dalen, et al.
Clinical Lung Cancer|November 7, 2016
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore ApproachErna-Elise Paulsen, Thomas K Kilvaer, Mehrdad Rakaee Khanehkenari, et al.
Scientific Reports|September 10, 2016
Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcomeThea Grindstad, Kaja Skjefstad, Sigve Andersen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung CancerRoy M Bremnes, Lill-Tove Busund, Thomas L Kilvær, et al.
Clinical Lung Cancer|February 4, 2018
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved SurvivalSigurd M Hald, Mehrdad Rakaee, Inigo Martinez, et al.
Pageof 5